Mark Souza Email

President and CEO . SonALAsense

Current Roles

Employees:
23
Revenue:
$3.6M
About
SonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent glioblastoma multiforme (rGBM) and other deadly cancers. SDT utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells.
SonALAsense Address
1111 Broadway
Berkeley, CA
SonALAsense Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.